Abnormal platelet aggregation in patients with Raynaud's phenomenon.
Open Access
- 1 July 1989
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 42 (7) , 716-718
- https://doi.org/10.1136/jcp.42.7.716
Abstract
Platelet aggregation in vitro to several aggregating agents (serotonin (5-HT), adenosine diphosphate, adrenaline and collagen) was studied in 16 patients with primary and secondary Raynaud's phenomenon and compared with that in 13 normal volunteers. Platelets from patients with Raynaud's phenomenon had significantly greater responses to all the 5-HT concentrations tested (p less than 0.001 for 10 microM; p less than 0.01 for 1 microM; p less than 0.05 for 0.1 microM; p less than 0.02 for 0.025 microM) and to low doses of adenosine diphosphate (p less than 0.01 for 1 microM; p less than 0.02 for 0.5 microM) but normal responses to collagen, adrenaline, and high doses of adenosine diphosphate. Patients with secondary Raynaud's phenomenon were significantly more hypersensitive to 0.5 microM adenosine diphosphate than patients with primary Raynaud's phenomenon. In patients with secondary Raynaud's phenomenon there was a significant correlation between the extent of 5-HT aggregation and the duration of the disease. The finding that platelets from patients with Raynaud's phenomenon have enhanced responses to 5-HT and adenosine diphosphate, but normal responses to adrenaline and collagen, is consistent with a role for 5-HT in this disease.This publication has 11 references indexed in Scilit:
- Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenonInternational Journal of Cardiology, 1988
- Ketanserin treatment and serotonin in patients with primary and secondary Raynaud's phenomenonEuropean Journal of Clinical Pharmacology, 1988
- Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.BMJ, 1986
- SELECTIVE ANTAGONISM OF S2-SEROTONERGIC RECEPTORS RELIEVES BUT DOES NOT PREVENT COLD INDUCED VASOCONSTRICTION IN PRIMARY RAYNAUDS-PHENOMENON1986
- EFFECT OF KETANSERIN ON RAYNAUDS-PHENOMENON IN PROGRESSIVE SYSTEMIC-SCLEROSIS - A DOUBLE-BLIND TRIAL1985
- Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.BMJ, 1984
- Assessment of platelet function in patients with Raynaud's syndrome.Journal of Clinical Pathology, 1984
- PLATELET ACTIVATION, FIBRINOLYTIC-ACTIVITY AND CIRCULATING IMMUNE-COMPLEXES IN RAYNAUDS-PHENOMENON1982
- Plasma exchange and platelet function in Raynaud's phenomenonThrombosis Research, 1980